Hollywood’s ‘new business model’ comes into view as Gen Z shows a moviegoing taste that combines ‘fast food and fine dining’

North American summer box office reached a nominal record of $4.765 billion, up 26.1% year over year and $9.3 million above the prior 2013 record, but inflation-adjusted revenue remained 17% below 2019 and ticket sales were roughly 249 million lower. The recovery is being driven by higher prices and premium formats: Cinemark's average U.S. ticket price rose 4.2% to $10.83, concession spending per patron increased 4.3% to $8.70, and premium large-format screens generated nearly 15% of box office from only 6% of auditoriums. Texas Capital forecasts a $2.85 billion third-quarter domestic box office and projects AMC/Cinemark adjusted EBITDA of $256 million/$259 million, respectively, if premium spending and cost discipline continue.

Analysis

The key equity implication is operating leverage, not a broad attendance recovery. CNK's cleaner balance sheet and structurally lower fixed-cost burden make incremental premium-ticket and concession dollars more likely to reach free cash flow; AMC's larger earnings torque is offset by refinancing, dilution, and interest-expense leakage. A sustained mix shift toward PLF should also favor IMAX disproportionately because its economics monetize scarce premium screens and film-specific marketing rather than aggregate theater traffic.

The next 1-3 month setup is unusually catalyst-dense: third-quarter results can validate whether per-patron spending converts into EBITDA above consensus, while December's event-film slate tests pricing elasticity. A strong opening weekend alone is insufficient; the investable confirmation is elevated admissions revenue per patron, concession spend, and forward booking trends without a rise in discounting. If those metrics hold, consensus estimates for CNK and IMAX likely remain too low because sell-side models still implicitly require a larger attendance recovery to justify margin expansion.

The contrarian risk is that a record nominal box office has encouraged investors to extrapolate price rather than volume. Fewer releases concentrate demand into tentpoles, creating volatile quarters and weaker utilization for exhibitors between events; this is especially problematic for AMC, whose capital structure leaves little room for a weak content window. Over 6-18 months, studios may capture more of the premium economics through shorter windows, direct ticketing, and differentiated large-format partnerships, limiting exhibitors' share of the value pool even if industry revenue stabilizes.

Key Decisions for Investors

• Initiate a 3-6 month long CNK / short AMC pair, sized dollar-neutral. CNK offers the superior conversion of premium mix into equity value, while AMC remains exposed to debt-service and equity-financing risk; reassess if AMC demonstrates material net-debt reduction or CNK's EBITDA margin fails to expand year over year.
• Accumulate IMAX ahead of December premium-format releases, preferably on post-earnings weakness rather than chasing opening-weekend headlines. Target a 6-month horizon; thesis is falsified if premium-screen utilization or per-screen box office declines despite event-film demand, indicating that pricing is displacing rather than adding admissions.
• Use CNK Q3 results as a confirmation gate: add only if management shows both higher per-patron revenue and EBITDA conversion above current consensus expectations, without relying on one-time release timing. A miss driven by discounting or softer food-and-beverage spend would invalidate the premiumization thesis and argues for no incremental theater exposure.
• Avoid a directional AMC long despite potential near-term headline torque from a strong holiday slate. Any upside should be treated as a trading opportunity unless liquidity disclosures show reduced financing needs; a weaker-than-expected December slate could widen its credit-risk discount quickly.